{
    "xml": "<topic id=\"PHP85607\" outputclass=\"drug\" rev=\"1.16\" type=\"drug\" namespace=\"/drugs/fluticasone-with-vilanterol\" basename=\"fluticasone-with-vilanterol\" title=\"FLUTICASONE WITH VILANTEROL\">\n<title>FLUTICASONE WITH VILANTEROL</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_1279\" namespace=\"/interactions/list-of-drug-interactions/sympathomimetics-beta2/vilanterol\">Vilanterol</xref>, <xref format=\"dita\" href=\"#bnf_int_497\" namespace=\"/interactions/list-of-drug-interactions/corticosteroids/fluticasone\">Fluticasone</xref>\n</p>\r\n<p outputclass=\"constituentDrugs\">The properties listed below are those particular to the combination only. For the properties of the components please consider, <xref format=\"dita\" href=\"#PHP1869\" namespace=\"/drugs/fluticasone\">fluticasone</xref>.</p>\n<data name=\"vtmid\">23662511000001107</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_832374428\" title=\"Corticosteroids\">Corticosteroids</xref>\n</data>\n</data>\r\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_531592176\" title=\"Beta2 agonists (long-acting)\">Beta2 agonists (long-acting)</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP87244\" outputclass=\"sideEffects\" rev=\"1.9\" parent=\"/drugs/fluticasone-with-vilanterol\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Abdominal pain</ph>; <ph outputclass=\"sideEffect\">back pain</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP87240\" outputclass=\"pregnancy\" parent=\"/drugs/fluticasone-with-vilanterol\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises use only if potential benefit outweighs risk.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP87230\" outputclass=\"breastFeeding\" parent=\"/drugs/fluticasone-with-vilanterol\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises avoid&#8212;no information available.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP87237\" outputclass=\"hepaticImpairment\" parent=\"/drugs/fluticasone-with-vilanterol\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p>Max. dose fluticasone furoate 92&#8239;micrograms, vilanterol 22&#8239;micrograms.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP87241\" outputclass=\"patientAndCarerAdvice\" rev=\"1.9\" parent=\"/drugs/fluticasone-with-vilanterol\">\n<title>Patient and carer advice</title>\n<body>\n<section outputclass=\"patientResources\">\n<sectiondiv>\n<p>A steroid card should be provided.</p>\n</sectiondiv>\n</section>\n<section outputclass=\"generalPatientAdvice\">\n<sectiondiv>\n<p>Patients or carers should be given advice on how to administer fluticasone with vilanterol powder for inhalation.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP87251\" outputclass=\"nationalFunding\" rev=\"1.11\" parent=\"/drugs/fluticasone-with-vilanterol\">\n<title>National funding/access decisions</title>\n<body>\n<section>\n<sectiondiv outputclass=\"smcDecisions\">\n<p outputclass=\"title\">Scottish Medicines Consortium (SMC) Decisions</p>\n<sectiondiv outputclass=\"smcDecision\">\n<sectiondiv>\n<p outputclass=\"specificity\">When used by <ph outputclass=\"route\">inhalation</ph>\n</p>\n<p>The <i>Scottish Medicines Consortium</i> has advised (March 2014) that fluticasone furoate/vilanterol (<i>Relvar Ellipta</i>\n<tm tmtype=\"reg\"/>) is accepted for restricted use within NHS Scotland in patients with severe chronic obstructive pulmonary disease with a forced expiratory volume in 1 second (FEV<sub>1</sub>) less than 50% of the predicted normal value.</p>\n</sectiondiv>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP85607-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/fluticasone-with-vilanterol\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP92259\" title=\"Inhalation powder\" namespace=\"/drugs/fluticasone-with-vilanterol/inhalation-powder\">Inhalation powder</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"2\" rel=\"backlink\">Drug classifications</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_1279\" namespace=\"/interactions/list-of-drug-interactions/sympathomimetics-beta2/vilanterol\" title=\"Vilanterol\" count=\"1\" rel=\"link\">Vilanterol</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_497\" namespace=\"/interactions/list-of-drug-interactions/corticosteroids/fluticasone\" title=\"Fluticasone\" count=\"1\" rel=\"link\">Fluticasone</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP1869\" namespace=\"/drugs/fluticasone\" title=\"FLUTICASONE\" count=\"1\" rel=\"link\">FLUTICASONE</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP92259\" namespace=\"/drugs/fluticasone-with-vilanterol/inhalation-powder\" title=\"Inhalation powder\" count=\"1\" rel=\"link\">Inhalation powder</xref>\n</links>\n</topic>",
    "id": "PHP85607",
    "outputclass": "drug",
    "rev": "1.16",
    "type": "drug",
    "namespace": "/drugs/fluticasone-with-vilanterol",
    "basename": "fluticasone-with-vilanterol",
    "title": "FLUTICASONE WITH VILANTEROL",
    "interactants": [
        {
            "id": "bnf_int_1279",
            "label": "Vilanterol"
        },
        {
            "id": "bnf_int_497",
            "label": "Fluticasone"
        }
    ],
    "constituents": [
        {
            "id": "PHP1869",
            "label": "fluticasone"
        }
    ],
    "vtmid": "23662511000001107",
    "drugClassification": [
        "Corticosteroids",
        "Beta2 agonists (long-acting)"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Abdominal pain",
                        "html": "Abdominal pain",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "back pain",
                        "html": "back pain",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        }
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises use only if potential benefit outweighs risk.",
                "html": "<p>Manufacturer advises use only if potential benefit outweighs risk.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises avoid&#8212;no information available.",
                "html": "<p>Manufacturer advises avoid&#8212;no information available.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "textContent": "Max. dose fluticasone furoate 92 micrograms, vilanterol 22 micrograms.",
                "html": "<p>Max. dose fluticasone furoate 92&#8239;micrograms, vilanterol 22&#8239;micrograms.</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "patientResources": [
            {
                "type": "patientResources",
                "textContent": "A steroid card should be provided.",
                "html": "<p>A steroid card should be provided.</p>"
            }
        ],
        "generalPatientAdvice": [
            {
                "type": "generalPatientAdvice",
                "textContent": "Patients or carers should be given advice on how to administer fluticasone with vilanterol powder for inhalation.",
                "html": "<p>Patients or carers should be given advice on how to administer fluticasone with vilanterol powder for inhalation.</p>"
            }
        ]
    },
    "nationalFunding": {
        "smcDecisions": [
            {
                "type": "smcDecisions",
                "textContent": "When used by inhalation The Scottish Medicines Consortium has advised (March 2014) that fluticasone furoate/vilanterol (Relvar Ellipta ) is accepted for restricted use within NHS Scotland in patients with severe chronic obstructive pulmonary disease with a forced expiratory volume in 1 second (FEV1) less than 50% of the predicted normal value.",
                "html": "<p outputclass=\"specificity\">When used by <ph outputclass=\"route\">inhalation</ph> </p> <p>The <i>Scottish Medicines Consortium</i> has advised (March 2014) that fluticasone furoate/vilanterol (<i>Relvar Ellipta</i> <tm tmtype=\"reg\"/>) is accepted for restricted use within NHS Scotland in patients with severe chronic obstructive pulmonary disease with a forced expiratory volume in 1 second (FEV<sub>1</sub>) less than 50% of the predicted normal value.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP92259",
                "label": "Inhalation powder",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_1279",
                "label": "Vilanterol",
                "type": "interaction"
            },
            {
                "id": "bnf_int_497",
                "label": "Fluticasone",
                "type": "interaction"
            }
        ],
        "drug": [
            {
                "id": "PHP1869",
                "label": "FLUTICASONE",
                "type": "drug"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP92259",
                "label": "Inhalation powder",
                "type": "medicinalForm"
            }
        ]
    }
}